Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Bionova Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2024-10-31.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 6 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-10-31 | 510(k) | K243181 | Foundation Dermal Regeneration Scaffold Plus (DRS+) Solo |
| 2024-08-21 | 510(k) | K240298 | Foundation Dermal Regeneration Scaffold Plus (DRS+) Duo |
| 2023-11-13 | 510(k) | K231937 | Foundation Dermal Regeneration Scaffold (DRS) Solo |
| 2022-08-11 | 510(k) | K210949 | Foundation Dermal Regeneration Scaffold (DRS) Solo |
| 2013-04-05 | 510(k) |
| K123961 |
| SENTREX BIOSPONGE MPD |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Bionova Medical.